Xencor (XNCR) news
Recent news
Xencor Q2 net income USD -21.729 million
AInvest Wire · Aug 5, 2026Xencor extends cash runway estimate through 2028
Xencor, Inc. (NASDAQ: XNCR) has updated its cash runway forecast, projecting that its existing cash and cash equivalents will be sufficient to fund operations through 2028, according to a recent SEC filing. This extension reflects the company’s ongoing efforts to optimize operational efficiency and…
AInvest Wire · Jul 29, 2026Xencor: first $52.5M payment from Alexion due August 2026
Xencor Inc. (XNCR) is set to receive a $52.5 million milestone payment from Alexion Pharmaceuticals in August 2026, as part of their ongoing collaboration agreement. The payment is tied to the achievement of specific developmental and regulatory milestones related to a jointly developed therapeutic…
AInvest Wire · Jul 29, 2026Xencor to receive $105M from Alexion in royalty settlement
AInvest Wire · Jul 29, 2026Xencor shares fall 13%
Xencor shares fall 13% Xencor (NASDAQ: XNCR) shares experienced a notable 13% decline on May 7, 2025, despite reporting positive interim results from a first-in-human study of XmAb942, an anti-TL1A antibody for inflammatory bowel disease. The study showed promising safety and efficacy data, with…
AInvest Wire · May 6, 2025Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.